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Abstract
Background: Recombinant galectins of male and female Haemonchus contortus (rHco-gal-m/f) have been recognized
as significant regulators of the functions of goat peripheral blood mononuclear cells (PBMC). In previous research,
transmembrane protein 63A (TMEM63A) was identified as a partner protein in the regulation associated with H. contortus
infection. However, in the identification of binding partners for galectins of male and female H. contortus (Hco-gal-m/f)
by yeast two-hybrid (YTH) screening, it was found that the transmembrane protein 147 (TMEM147) could also bind
to Hco-gal-m/f. In this study, the functions of TMEM147 in the regulations of H. contortus galectin on the goat PBMC
were investigated.
Methods: To identify Hco-gal-m/f-interacting proteins, a yeast two-hybrid system to detect interactions was used.
Co-immunoprecipitation and immunoblotting were used to validate the interaction between recombinant galectins of
male H. contortus (rHco-gal-m) and candidate binding protein. The localization of TMEM147 in PBMC was explored by
immunofluorescence in confocal imaging studies. Flow cytometry was used to determine the distribution of TMEM147
in T cells, B cells and monocytes in PBMC. The modulatory effects of rHco-gal-m and TMEM147 on cell proliferation,
phagocytosis, nitric oxide production, migration, apoptosis and cytokine mRNA transcription were observed by
co-incubation of rHco-gal-m and knockdown of the tmem147 gene.
Results: In this research, it was demonstrated that TMEM147 could bind to rHco-gal-m/f. Immunofluorescence assays
showed that TMEM147 was localized to the cell membrane and within the cell membrane in goat PBMC. Flow
cytometric analysis revealed that TMEM147 was expressed in all B cells and monocytes in goat PBMC. However,
3.8 % of T cells did not express this protein. Knockdown of the tmem147 gene using RNA interference (RNAi)
showed that the interaction of galectin with TMEM147 mainly mediated cell proliferation, cell apoptosis, transcription
of interleukin-10 (IL-10) and transforming growth factor-β1 (TGF-β1) of goat PBMC. This membrane protein, together
with TMEM63A, was also related to the regulation of galectin on phagocytosis and nitric oxide production of goat
PBMC. However, it might not be involved in the regulation of galectin on the migration and interferon-γ (IFN-γ)
transcription of goat PBMC.
Conclusions: Our results showed that TMEM147 was a binding partner of Hco-gal-m/f and mediated the
immunological regulation of Hco-gal-m/f on goat PBMC in a manner different to that of TMEM63A.
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Background
Haemonchus contortus is a gastrointestinal parasitic
nematode in ruminants (notably goats and sheep) that
feeds on blood in the abomasum [1]. Infections with H.
contortus can lead to anaemia, weight loss and death,
and causes substantial economic losses to livestock pro-
duction worldwide [2]. Galectins are an evolutionarily
ancient family of proteins, closely related to carbohydrate-
binding proteins, and located either intracellularly or
extracellularly [3–6]. To date, 15 mammalian galectins
(galectin-1 to 15) have been cloned and functionally
characterized [7]. They can function as important
immunological mediators of homeostasis and disease
regulation, and display a remarkable functional diversity
by participating in the regulation of cell differentiation,
proliferation, migration, activation, apoptosis and cytokine
production [4–6, 8].
Galectins can be produced by both the parasite and
the host. Subsequent studies suggested that parasite
galectin might play an important role in host-parasite in-
teractions [9]. It was demonstrated that galectin-1 might
mediate Trichomonas vaginalis adherence to human cer-
vical epithelial cells by binding to T. vaginalis lipopho-
sphoglycan (LPG) [10], and modulate macrophage
apoptosis during infection with Trypanosoma cruzi [11].
Galectin-3 was reported to be involved in biological pro-
cesses that affected the replication of Plasmodium yoelii
[12, 13]. Furthermore, galectin-3 could significantly alter
the pathogenic course of Toxoplasma gondii [14],
Trypanosoma cruzi [15] and Leishmania major [16]. In
additional to galectin-1 and galectin-3, other galectins are
also involved in host-parasite interactions. For example,
galectin-9 could recognize L. major by binding to the L.
major-specific polygalactosyl epitope [17], and negatively
regulate helper T cell 2-mediated (Th2-mediated) eosino-
philic lung inflammation during infection with Ascaris
suum [18]. Alternatively, transcription and expression of
galectin-11 was increased in the abomasal mucosa follow-
ing Ostertagia ostertagi infection [19]. Galectin-14 was
identified in the mucosal wash from ovine abomasum fol-
lowing Teladorsagia circumcincta larval challenge [20],
and was significantly negatively correlated with worm
burden following a challenge infection with H. contortus
third-stage larvae (L3s) [21].
In addition to the above functions, galectins from
mammals could also bind to appropriate receptors on
the cell surface and participate in a number of biological
processes. It has been reported that binding of galectin-3
to mucin 1 (MUC1) could promote tumor cell malig-
nancy [22] and the cell surface interaction of annexin
A2 and galectin-3 could also modulate epidermal growth
factor receptor signaling in epidermal growth factor
receptor-2 (Her-2) negative breast cancer cells [23].
However, there are few reports regarding the binding
partners of these galectins in the host. Therefore, research
into the molecular mechanisms that govern the interac-
tions between these galectins and host molecules will shed
a new light on galectin-mediated immunomodulation.
In previous research, galectins of male H. contortus
(Hco-gal-m) (Acc. No. AY253330) and galectins of fe-
male H. contortus (Hco-gal-f ) (Acc. No. AY253331) were
demonstrated to be two isoforms of galectin derived
from male and female H. contortus, respectively [24]. It
has also been suggested that recombinant Hco-gal-m/f
(rHco-gal-m/f ) could bind to the surface of goat PBMC
in vitro, and induce biological effects, including pro-
moting cell apoptosis and altering the transcription of
interleukin-1β (IL-1β), interleukin-4 (IL-4), IL-10,
TGF-β1, IFN-γ and tumor necrosis factor-α (TNF-α)
mRNA [25–27]. Furthermore, transcriptional and prote-
omic analyses revealed that rHco-gal-m/f could modulate
several signaling cascades in vitro, including the activation
of vascular endothelial growth factor pathway, free radical
producing pathway, nuclear factor-kappa B (NFkB) path-
way and the ubiquitin-proteasome pathway [25].
In our previous study, TMEM63A of goat PBMC was
identified to be a receptor of Hco-gal-m/f and knock-
down of the tmem63a gene by RNAi altered cell pro-
liferation, phagocytosis, nitric oxide production and
cytokine mRNA transcription of goat PBMC induced by
Hco-gal-m/f [27]. However, in the identification of bind-
ing partners for Hco-gal-m and Hco-gal-f by yeast two-
hybrid (YTH) screening, it was found that TMEM147
and TMEM63A simultaneously bound to Hco-gal-m/f.
However, the functions of TMEM147 in the regulation
of Hco-gal-m/f on the PBMC remain unclear and
whether TMEM147 is another receptor or partner pro-
tein of Hco-gal-m/f on goat PBMC is also unknown. In
this study, the functions of TMEM147 in the regulation
of H. contortus galectin on the goat PBMC were ob-
served and the results showed that TMEM147 was an-
other partner protein of Hco-gal-m/f. It mediated the
functions of goat PBMC induced by Hco-gal-m/f differ-
ently with that of TMEM63A.
Methods
Animals and cells
Local crossbred goats (3–6 month-old) from the teach-
ing and research flock at Nanjing Agricultural University
were housed indoors in pens. They were fed with hay
and whole shelled corn and provided with water ad
libitum. All goats were dewormed twice at 2 weekly
intervals with levamisole (8 mg/kg bodyweight) orally at
the time of housing to remove naturally acquired strongy-
lid infections [28]. According to standard parasitological
techniques, after two weeks, the helminth eggs in fecal sam-
ples from each goat were detected by microscopy. Goats
evincing no eggs were used in the subsequent study and
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the health was observed daily throughout the experiment.
The isolation and culture of goat PBMCs and monocytes
were performed as previously described [27].
Identification of binding partners for Hco-gal-m and
Hco-gal-f by yeast two-hybrid (YTH) screening
The identification of binding partners for Hco-gal-m/f
was performed as previously described using YTH
screening [27].
Validation of the interaction between rHco-gal-m and
TMEM147 by co-immunoprecipitation (co-IP) and
immunoblotting
To validate the interaction between rHco-gal-m and
candidate binding proteins, the forward IP and reverse
IP experiments were performed independently as previ-
ously described [27]. The goat PBMC stimulated with
rHco-gal-m for 12 h were pelleted and lysed. After pre-
clearing treatment, triplicate 1 mg lysates were each in-
cubated separately overnight at 4 °C with the following:
rat anti-TMEM147-O immunoglobulin G (IgG) for input
samples, rat anti-Hco-gal IgG for IP samples and normal
rat IgG (Santa Cruz Biotechnology, Dallas, Texas, USA)
for negative control samples in forward IP; rat anti-Hco-
gal IgG for input samples, rat anti-TMEM147-O IgG for
IP samples, normal rat IgG for negative control samples
in reverse IP. Immune complexes were precipitated by
20 μl protein A/G PLUS-Agarose beads (Santa Cruz
Biotechnology, Texas, USA) following the manufac-
turer’s protocol.
Immunoblotting assays were performed following co-
IP according to the methods previously described [27].
The membrane was incubated with the respective pri-
mary antibodies: rat anti-TMEM147-O IgG for forward
IP experiment or rat anti-Hco-gal IgG for reverse IP
experiment overnight at 4 °C. Antibodies and the
production of antibodies used in these experiments are
described in Additional file 1: Protocols (Production of
antibody); Additional file 2: Table S1; and Additional
file 3: Figures S1–S4.
Detection of the localization of TMEM147 in PBMC by
immunofluorescence (IF)
The IF assay was performed according to previous
research [27]. The fixed and permeabilized PBMC
(105 cells/sample) were incubated with 0.5 μg of the re-
spective primary antibodies, rat anti-TMEM147-O IgG or
negative rat IgG (for negative control) and incubated with
the secondary antibody coupled to Cyanine dyes 3 (Cy3)
fluorescent dye (Beyotime Biotechnology, Haimen, Jiangsu,
China) (1:300). Cells were then stained with 5 μM
3,3'-Dioctadecyloxacarbocyanine (DiOC18(3); Beyotime
Biotechnology, Haimen, Jiangsu, China) and 1.5 μM
2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride
(DAPI; Sigma, St. Louis, Missouri, USA), respectively, for
6 min each. Protein localization was observed with a
100× oil objective lens on a laser scanning confocal
microscope (LSM710, Zeiss, Jena, Thuringia, Germany).
Digital images were captured using the Zeiss micro-
scope software package ZEN 2012 (Zeiss, Jena, Thuringia,
Germany).
Detection of the distribution of TMEM147 in T cells, B
cells and monocytes in PBMC by flow cytometry
The distribution of TMEM147 in T cells and monocytes
in PBMC were detected as previously described using
flow cytometry [27]. PBMC (106 cells/reaction), isolated
as described above, were firstly stained with anti-
bodies: 1 μg mouse anti-bovine cluster of differentiation
2-fluorescein isothiocyanate (CD2-FITC), 1 μg mouse
anti-bovine cluster of differentiation 21-fluorescein iso-
thiocyanate (CD21-FITC) and 1 μg mouse anti-bovine
cluster of differentiation 14-fluorescein isothiocyanate
(CD14-FITC) (AbDSerotec, Bio-Rad Laboratories, Hercules,
California, USA), respectively, at 4 °C for 30 min. After
permeabilization and washing, cells were then incubated
with 1 μg rat anti-TMEM147-O IgG for 1 h and chicken
anti-rat immunoglobulin G-phycoerythrin (IgG-PE) (1:300,
Santa Cruz Biotechnology, Dallas, Texas, USA) for 30 min
at room temperature. Normal mouse immunoglobulin
G1-fluorescein isothiocyanate (IgG1-FITC) (Santa Cruz
Biotechnology, Dallas, Texas, USA) and negative rat IgG
(1 μg) were used to set a ‘fluorescence minus one’ control.
Samples were examined on a FACS Calibur™ flow cyt-
ometer (BD Biosciences, San Jose, California, USA). Data
were analyzed using FlowJo 7.6 software (Tree Star,
Ashland, Oregon, USA).
Small interfering RNA and cell treatment
Three small interfering RNAs (siRNA) were designed to
knockdown the tmem147 gene (Additional file 2: Table S2).
TMEM147-siRNA-1, with the highest interference effi-
ciency, was selected for further experiments (Additional
file 1: Protocols (Transfection procedures for siRNA) and
Additional file 3: Figure S5). The siRNAs used in this
study were chemically synthesized by Invitrogen (Life
Technologies, Shanghai, China) and dissolved in RNase-
free water to 20 μM. The time required for knockdown
was also determined (Additional file 1: Protocols
(Transfection procedures for siRNA) and Additional file 3:
Figure S5). The non-specific siRNA (ns siRNA) sequences
used in the experiment are listed in Additional file 2:
Table S2.
Cells were treated with siRNA transfection and then
rHco-gal-m was added as stimulation. The concentra-
tion of rHco-gal-m (40 μg/ml) has been demonstrated to
produce a distinct biological response without causing
toxicity to the cells by previous dose response studies
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[26, 29, 30]. Cells for the RNAi period are shown as a
blank group (group 1), ns siRNA group (group 2), ns
siRNA/g group (group 3), 147-siRNA group (group 4)
and 147-siRNA/g group (group 5), which were incubated
with an equal volume of reduced serum medium
(group 1), ns siRNA (groups 2 and 3) and TMEM147-
siRNA-1 (groups 4 and 5), for 60 h at a concentration of
1 × 106 cells/ml. rHco-gal-m in all RNAi groups
(groups 3 and 5) was added 12 h before the end of
the RNAi period [27].
Cell proliferation assay
At the end of the RNAi period, cell proliferation assay of
PBMC was performed as previously described using a cell
counting kit-8 assay reagent (Beyotime Biotechnology,
Haimen, Jiangsu, China) [27]. Cells in the blank group
served as controls and the OD450 was set as 100 %. The
cell proliferation index was calculated using the formula:
OD450 group/OD450 control.
Cell phagocytosis assay
Monocytes were collected at the end of the RNAi period
and incubated with 1 mg/ml fluorescein isothiocyanate-
dextran (FITC-dextran) (Sigma, St. Louis, Missouri,
USA) in Roswell Park Memorial Institute 1640 (RPMI
1640; GIBCO, Grand Island, New York, USA) at 37 °C
for 1 h [31]. The reaction was stopped using cold phos-
phate buffered saline (PBS) containing 2 % fetal bovine
serum. Cells were washed three times and resuspended
in PBS containing 2 % paraformaldehyde. The FITC-
dextran internalization of monocytes was analyzed by
flow cytometry (BD Biosciences, San Jose, California,
USA). Data were analyzed using FlowJo 7.6 software
(Tree Star, Ashland, Oregon, USA) and the cell phago-
cytosis index was calculated by considering the statistical
data of Median Fluorescence Intensity (MFI) values in
the blank group as 100 %.
Measurement of nitric oxide (NO) production
According to a previous study using Total Nitric Oxide
Assay Kit (Beyotime Biotechnology, Haimen, Jiangsu,
China) [27], the NO production assay was performed by
detecting intracellular nitrite in the PBMC with the
Griess assay [32]. Absorbance was determined using a
plate reader (Bio-Rad Laboratories, Hercules, California,
USA) at 540 nm (OD540) and then converted to micro-
moles per liter using a standard curve generated by the
addition of 0 to 80 μmol/l of sodium nitrite to fresh
culture media.
Cell migration assay
At the end of the RNAi period, the migration assay of
PBMC was performed as previously described using
Millicell® insert with 8.0 μm pores (Merck Millipore,
Darmstadt, Hessen, Germany) [27]. The cells that mi-
grated through the membrane into the lower chamber
were determined with a Neubauer counting chamber.
The results were presented as percentages of the seeded
PBMC. Each experiment was performed in triplicate.
Apoptosis assay
The Annexin V-FITC kit (Miltenyi Biotec, Bergisch
Gladbach, Nordrhein-Westfalen, Germany) was used to
estimate cell apoptosis, according to the manufac-
turer’s instructions. At the end of RNAi period, cells
(1 × 106 cells/ml) were harvested and used to check the
apoptosis using the flow cytometer (BD Biosciences, San
Jose, California, USA.). Data were analyzed using FlowJo
7.6 software (Tree Star, Ashland, Oregon, USA).
Detection of cytokine transcription
40 μl of vehicle (PBS, unstimulated negative control) or
rHco-gal-m at 1 μg/μl was added to the PBMC to yield a
final volume of 1 ml per well and incubated for 12 h
before the end of the RNAi period. The detection of
cytokine transcription was performed as previously de-
scribed by real-time PCR [27]. The reactions and condi-
tions of real-time PCR are detailed in Additional file 1:
Protocols (Real-time PCR reactions and conditions), and
the primers for real-time PCR are listed in Additional
file 2: Table S3. The amplification efficiencies of all tar-
gets and endogenous reference genes were verified to be
similar by real-time PCR (Additional file 2: Table S3).
Raw cycle thresholds (Ct), obtained from the ABI Prism
7500 software (version 2.0.6; Applied Biosystems, Foster
City, California, USA), were used for the comparative Ct
(2-ΔΔCt) method [33].
Statistical analysis
Statistical analysis for significant differences was per-
formed using the Graphpad Premier 6.0 software pack-
age (Graphpad Prism, San Diego, California, USA) at
P < 0.001. Data were expressed as the mean ± the
standard deviation (SD).
Results
TMEM147 is a novel binding protein for Hco-gal-m and -f
YTH screening assays were performed to find the bind-
ing partners of Hco-gal-m and -f from a goat PBMC
cDNA library constructed previously [27]. Following two
rounds of YTH screening, 20 clones encoding proteins
were found to interact with the Hco-gal-m and -f pro-
teins in yeast cells. Using DNA sequencing and BLASTn
of GenBank, four genes products were identified. Besides
TMEM63A, one of the products was TMEM147 (NCBI
accession number JQ923484). Moreover, the amino acid
sequences of TMEM147 were used to predict the
transmembrane structure by TMHMM Server v.2.0
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(http://www.cbs.dtu.dk/services/TMHMM/), and the re-
sults detailed in Additional file 3: Figure S4 indicate that
TMEM147 has 7 transmembrane domains and largely
resides within the membrane. As the same candidate
proteins were identified using either Hco-gal-m or Hco-
gal-f as bait, only rHco-gal-m was used in subsequent
experiments as a representative protein [27, 28].
Co-IP assays demonstrated that rHco-gal-m could bind to
TMEM147
To confirm the results of YTH screening, two independent
co-IP assays were performed in rHco-gal-m-stimulated
(12 h) goat PBMC. After immunoblotting, TMEME147
were detected in rHco-gal-m immune complexes (IP) and
in the PBMC lysates (Input), but not in the rat normal IgG
control (IgG) group (Fig. 1a). Reciprocally, in the reverse
co-IP assay, rHco-gal-m was detected in TMEM147 im-
mune complexes (IP) and in the PBMC lysates (Input), but
not in the rat normal IgG control (IgG) group (Fig. 1b).
The results of the co-IP assays strongly indicated that the
interactions of Hco-gal-m with TMEM147 in PBMC was
the result of specific binding.
TMEM147 was localized to the cell membrane and within
the cell membrane in PBMC
Using IF assay, the location of TMEM147 was detected
in intact and permeabilized PBMC. Confocal microscopy
images show that TMEM147 was found on the cell sur-
face in intact cells (Fig. 2). However, TMEM147 could
also be found in the cytosol of permeabilized cells
(Fig. 2). In the control group, no red fluorescence was
observed (Fig. 2).
TMEM147 was expressed in T cells, B cells and monocytes
of goat PBMC
In this study, the frequencies of TMEM147+ T cells
(TMEM147+/CD2+) were 48.9 % and 3.8 % TMEM147−
T cells (TMEM147−/CD2+) (Fig. 3a). The frequencies of
TMEM147+ B cells (TMEM147+/CD21+, 32.6 %) were
approximately similar to the frequency of total B cells
(CD21+, 32.6 % + 0.052 %, Fig. 3b). TMEM147+ mono-
cytes (TMEM147+/CD14+, 14.2 %) were approximately
100 % of total monocytes (CD14+, 14.2 % + 0.00 %) in
PBMC (Fig. 3c). These results indicate that the majority
of goat PBMC expressed TMEM147.
Fig. 1 Co-IP assays indicate that rHco-gal-m can bind to TMEM147. Lane Input (a, b): Cell lysates were precipitated with rat anti-TMEM147-O IgG
and rat anti-Hco-gal IgG. Lane IP (a, b): Cell lysates were precipitated with rat anti-Hco-gal IgG and rat anti-TMEM147-O IgG, respectively. Lane IgG
(a, b): Cell lysates were precipitated with normal rat IgG. Immunoblot analysis using rat anti-TMEM147-O IgG and rat anti-Hco-gal IgG demonstrated
that rHco-gal-m could bind to TMEM147. IP: immunoprecipitation
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Fig. 2 TMEM147 localized to the cell membrane and within the cell membrane in PBMC. Localization was carried out by incubation of cells with
rat anti-TMEM147-O IgG (TMEM147) or negative rat IgG (Control). DIO (green), DAPI (blue) and Cy3-conjugated secondary antibodies (red) were
utilized for triple staining. a, d, g: Cell membrane (green) and nuclei (blue) staining of cells. b, e, h: Staining of target proteins (red). c, f, i: A merged
image of the three colors. TMEM147 localized to the cell membrane and within the cell membrane. Scale-bars: 10 μm
Fig. 3 Analysis of TMEM147 expression in goat PBMC by flow cytometry. T cell (a), B cell (b) and monocyte (c) populations were identified using FITC-CD2,
FITC-CD21 and FITC-CD14 (X-axis). a Q1: TMEM147+/CD2−; Q2: TMEM147+/CD2+; Q3: TMEM147−/CD2+; Q4: TMEM147−/CD2. b Q1:TMEM147+/CD21−;
Q2: TMEM147+/CD21+; Q3: TMEM147−/CD21+; Q4: TMEM147−/CD21−. c Q1: TMEM147+/CD14−; Q2: TMEM147+/CD14+; Q3: TMEM147−/CD14+;
Q4: TMEM147−/CD14−. The percentages of cells with different staining patterns are shown. The results presented here are representative of three
independent experiments
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rHco-gal-m affected PBMC proliferation by the interaction
with TMEM147
Results showed that there was no PBMC multiplication
in the ns siRNA group induced by the ns siRNA-
treatment compared to the blank group (Fig. 4). Fur-
thermore, PBMC proliferation in the ns siRNA/g group
was significantly decreased (ANOVA, F(4, 25) = 28.23,
P < 0.0001) by rHco-gal-m compared to the ns siRNA
group (Fig. 4). After TMEM147 siRNA-treatment, PBMC
proliferation in the 147 siRNA/g group was significantly
increased (ANOVA, F(4, 25) = 28.23, P < 0.0001) compared
to the ns siRNA/g group (Fig. 4). No significant difference
(ANOVA, F(4, 25) = 28.23, P = 0.0196) was induced by
rHco-gal-m between the 147 siRNA/g and 147 siRNA
groups. In addition, no significant difference (ANOVA,
F(4, 25) = 28.23, P = 0.1271) was observed between the ns
siRNA and 147 siRNA groups (Fig. 4).
rHco-gal-m affected monocytes phagocytosis by the
interaction with TMEM147
The cell phagocytosis assay was performed to explore the
possible effects of TMEM147 and rHco-gal-m on mono-
cyte phagocytosis in goat PBMC. After rHco-gal-m-treat-
ment, monocyte phagocytosis in the ns siRNA/g group
was significantly decreased (ANOVA, F(4, 15) = 63.69,
P = 0.0001) compared to the ns siRNA group (Fig. 5).
However, monocyte phagocytosis in 147 siRNA/g was sig-
nificantly increased compared to the 147 siRNA group
(ANOVA, F(4, 15) = 63.69, P < 0.0001) and ns siRNA/g
group (ANOVA, F(4, 15) = 63.69, P < 0.0001) (Fig. 5). No
significant difference (ANOVA, F(4, 15) = 63.69, P = 0.9789)
was induced by TMEM147 siRNA-treatment between the
147 siRNA and ns siRNA groups (Fig. 5).
rHco-gal-m affected PBMC nitric oxide production by the
interaction with TMEM147
When PBMC were incubated with rHco-gal-m, nitric
oxide production in the ns siRNA/g group was signifi-
cantly suppressed (ANOVA, F(4, 10) = 55.70, P = 0.0008)
by rHco-gal-m compared to ns siRNA group (Fig. 6).
After TMEM147 siRNA-treatments, there was no influ-
ence (ANOVA, F(4, 10) = 55.70, P = 0.3917) on PBMC
nitric oxide production in the 147 siRNA group com-
pared with the ns siRNA group (Fig. 6), whilst the nitric
oxide production in 147 siRNA/g was significantly in-
creased (ANOVA, F(4, 10) = 55.70, P = 0.0006) compared
to the 147 siRNA group and ns siRNA/g group (Fig. 6).
The interaction of rHco-gal-m with TMEM147 might not
mediate PBMC migration
In order to explore the impact of TMEM147 knockdown
and rHco-gal-m/f-treatment on PBMC migration, a cell
migration assay was performed using Millicell® insert. No
significant difference (ANOVA, F(4, 15) = 103.3, P = 0.6838)
was observed between the blank group (41.03 ± 2.69 %)
and ns siRNA group (42.25 ± 3.04 %). Consistent with pre-
vious studies, the percentage of migrating PBMC in the ns
siRNA/g group (16.66 ± 1.41 %) was significantly de-
creased (ANOVA, F(4, 15) = 103.3, P < 0.0001) compared
to the ns siRNA group. However, after TMEM147
siRNA-treatment, the decrease in 147 siRNA/g group
(20.72 ± 1.41 %) was still prominent (ANOVA, F(4, 15) =
Fig. 4 rHco-gal-m affected the PBMC proliferation by the interaction
with TMEM147. Cell proliferation index was calculated considering
the OD450 values in blank group as 100 %. Results presented here
are representative of three independent experiments. Data are
presented as the mean ± SD (n = 6); *P < 0.001 versus the ns siRNA
group; an asterisk and a capped line designate two groups that
differ significantly (P < 0.001)
Fig. 5 rHco-gal-m affected the monocytes phagocytosis by the
interaction with TMEM147. Cell phagocytosis index was calculated
considering statistic data of MFI (Median Fluorescence Intensity) values
in blank group as 100 %. Results presented here are representative of
three independent experiments. Data are presented as the mean ± SD
(n = 4); *P < 0.001 versus the ns siRNA group; an asterisk and a capped
line designate two groups that differ significantly (P < 0.001)
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103.3, P < 0.0001) compared to the 147 siRNA group
(41.03 ± 2.69 %). No significant difference (ANOVA,
F(4, 15) = 103.3, P = 0.9620) between 147 siRNA and ns
siRNA groups was induced by TMEM147 siRNA-
treatment (Fig. 7). There was also no significant difference
(ANOVA, F(4, 15) = 103.3, P = 0.2322) between the
147 siRNA/g and ns siRNA/g groups induced by
TMEM147 siRNA-treatment (Fig. 7).
rHco-gal-m affected the apoptosis of goat PBMC by the
interaction with TMEM147
To explore the impact of TMEM147 knockdown and
rHco-gal-m/f-treatment on PBMC apoptosis, a cell
apoptosis assay was performed. The externalization of
membrane phosphatidylserine (PS) was used as a marker
of cell apoptosis and the positive DNA staining was used
as an indicator of membrane leakage. No significant
change (ANOVA, F(4, 10) = 80.93, P = 0.8863) on apop-
tosis was observed between the blank and ns siRNA
groups (Fig. 8). The percentage of apoptotic cells in the ns
siRNA/g group was dramatically augmented (ANOVA,
F(4, 10) = 80.93, P < 0.0001) by rHco-gal-m compared to
the ns siRNA group (Fig. 8). After knockdown of the
tmem147 gene, the apoptosis induced by rHco-gal-m in
the 147 siRNA/g group was significantly suppressed
(ANOVA, F(4, 10) = 80.93, P = 0.0023) by TMEM147
siRNA-treatment compared to the ns siRNA/g group
(Fig. 8). Moreover, the increase of apoptotic cells induced
by rHco-gal-m between the 147 siRNA and 147 siRNA/g
groups was diminished in TMEM147 siRNA-treated cells
(Fig. 8). Meanwhile, there was a significant increase
(ANOVA, F(4, 10) = 80.93, P = 0.0020) between the ns
siRNA and the 147 siRNA groups (Fig. 8).
The interaction of rHco-gal-m with TMEM147 affected the
transcription of cytokines in goat PBMC
After treatments by ns or TMEM147 siRNA, the goat
PBMC were stimulated by PBS (vehicle) or rHco-gal-m.
Real-time PCR analyses demonstrated that the transcrip-
tion of IL-10 (ANOVA, F(3, 8) = 199.2, P < 0.0001) and
TGF-β1 (ANOVA, F(3, 8) = 364.3, P < 0.0001) in non-
specific siRNA-treated cells were significantly increased
by rHco-gal-m (Fig. 9b, c), whilst the transcription of
IFN-γ in non-specific siRNA-treated cells was promin-
ently suppressed (ANOVA, F(3, 8) = 949.5, P < 0.0001) by
rHco-gal-m (Fig. 9a). Exposure of TMEM147 siRNA-
treated cells to rHco-gal-m significantly decreased tran-
scription of IL-10 (ANOVA, F(3, 8) = 199.2, P < 0.0001)
and TGF-β1 (ANOVA, F(3, 8) = 364.3, P < 0.0001) mRNA,
whilst transcription of IFN-γ in the cells was not
affected (ANOVA, F(3, 8) = 949.5, P = 0.9994).
Transcription of IL-10 (ANOVA, F(3, 8) = 199.2, P < 0.0001)
and TGF-β1 (ANOVA, F(3, 8) = 364.3, P < 0.0001) in
rHco-gal-m-treated cells were significantly diminished
by TMEM147 siRNA-treatment, but unaffected (ANOVA,
F(3, 8) = 199.2, P = 0.1505 for IL-10; F(3, 8) = 364.3, P =
0.0080 for TGF-β1) in PBS-treated cells (Fig. 9b, c).
Notably, the transcription of IFN-γ in TMEM147
siRNA group were all prominently decreased
(ANOVA, F(3, 8) = 949.5, P < 0.0001) compared to the
non-specific siRNA group by the same stimuli
(Fig. 9a).
Fig. 7 The interaction of rHco-gal-m with TMEM147 might not mediate
the PBMC migration. The data are presented as box-and-whiskers plot,
with the box containing 50 % of the values, and the whiskers showing
the highest and the lowest values. The median is indicated by the
horizontal bar, the mean value as square. Results presented here
were collected from one independent experiment (n = 4) and are
representative of three independent experiments; an asterisk and a
capped line designates two groups that differ significantly (P < 0.001)
Fig. 6 rHco-gal-m affected the PBMC nitric oxide production by the
interaction with TMEM147. Results presented here are representative of
three independent experiments. Data are presented as the mean ± SD
(n = 4); *P < 0.001 versus the ns siRNA group; an asterisk and a capped
line designate two groups that differ significantly (P < 0.001)
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Discussion
TMEM147 is a highly conserved membrane protein
amongst mammals and widely expressed in many
peripheral and central tissues whose function is still be-
ing elucidated. Rosemond et al. [34] reported that
TMEM147 is a binding protein of M3R M3 muscarinic
acetylcholine receptor and might act as a potent negative
regulator of M3R function by changing the stimulatory
effects of carbachol on H508 human colon cancer cell
proliferation and p90 ribosomal S Kinase (p90RSK) activa-
tion. Dettmer et al. [35] suggested that TMEM147 was also
a binding partner of a membrane protein complex, the
Nicastrin-like protein-Nodal modulator (Nicalin-NOMO)
complex. Nodal factors can initiate signaling cascades
and drive the transcription of specific genes which
affect cell proliferation [36]. Combined, these indicate
that TMEM147 may have important functional roles
in physiological processes. In this study, YTH screening
and co-IP assays demonstrated that TMEM147 could bind
to Hco-gal-m and Hco-gal-f. After knockdown of the
tmem147 gene by RNAi, the influence of rHco-gal-m on
proliferation, phagocytosis, nitric oxide production, apop-
tosis and cytokine expression of the siRNA-treated cells
were all changed. This indicated that TMEM147 mediated
the regulation of rHco-gal-m on the goat PBMC.
Rosemond et al. [34] and Dettmer et al. [35] reported
that TMEM147 localized to the endoplasmic reticulum
(ER) membranes of co-transfected mammalian cells
(COS-7 cells) and was enriched in ER membranes in
HeLa cells. However, in this study, it was found that
TMEM147 localized to both the cell surface and the in-
side of cells (Fig. 2). It was therefore suspected that
Fig. 8 a Analysis of PBMC apoptosis by flow cytometry. Apoptosis of PBMC was determined by staining with annexin V and PI followed by flow
cytometric analysis. The percentages of cells with different staining patterns are shown. The results presented here are representative of three
independent experiments. b rHco-gal-m affected the apoptosis of goat PBMC by the interaction with TMEM147. The percentage of apoptosis was
measured on four separate occasions. Results presented here are representative of three independent experiments. Data are presented as the
mean ± SD (n = 3); an asterisk and a capped line designate two groups that differ significantly (P < 0.01); double asterisk and a capped line designates
two groups that differ highly significantly (P < 0.001)
Fig. 9 Relative levels of cytokine mRNA transcripts in goat PBMC pretreated with negative or TMEM147 siRNA. Goat PBMC pretreated with TMEM147
siRNA were stimulated by PBS (vehicle) or rHco-gal-m. a IFN-γ. b IL-10. c TGF-β1. Data are presented as the mean ± SD (n = 3). Significant differences
between the two stimulation conditions for each RNAi group are indicated by different lower case letters (P < 0.001). The asterisk (*) designates that
the mean of the TMEM147 knockdown group differs significantly from the mean of the negative siRNA group (P < 0.001) for a stimulation condition.
Results presented here are representative of three independent experiments
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TMEM147 might have different localizations in different
kinds of cells. Our data suggest that TMEM147 was
expressed by all B cells, monocytes and most T cells in
goat PBMC (Fig. 3). Wang et al. [28] reported that dif-
ferent PBMC subsets had distinct responses to stimula-
tion of rHco-gal-m/f. Hence, the specific functions of
TMEM147 expressed by specific cell subsets and the na-
ture and functions of these TMEM147-negative cells
needs to be further investigated.
It has been suggested that TMEM147 was implicated
in the regulation of cell proliferation [34, 35], and rHco-
gal-m inhibited the proliferation of T cells in goat PBMC
in vitro [27, 28]. In this study, it was found that the co-
incubation with rHco-gal-m significantly suppressed the
PBMC proliferation in the ns siRNA-treated cells, while
the PBMC proliferation in rHco-gal-m-treated cells was
significantly increased after TMEM147 siRNA-treatment
(Fig. 4). It indicated that TMEM147 played a key role in
the regulation of rHco-gal-m on the PBMC proliferation.
In a previous study, TMEM63A specific siRNA-
treatment could not effectively reverse the inhibition of
rHco-gal-m on the PBMC proliferation [27]. So the
modulation of cell proliferation in goat PBMC by rHco-
gal-m was mainly mediated by TMEM147, but not
TMEM63A.
It was demonstrated that phagocytosis could make a
contribution to the clearance of damaged cells and host
defense against pathogens, and a number of galectin
family members have been shown to play an important
role in phagocytosis [37]. In this study, the phagocytosis
of monocytes in the ns siRNA/g group was significantly
suppressed by rHco-gal-m (Fig. 5). After TMEM147
siRNA-treatment, the phagocytosis of monocytes in the
147 siRNA/g group was significantly increased compared
to the 147 siRNA group and ns siRNA/g group (Fig. 5).
It is therefore expected that the interaction between
Hco-gal-m and TMEM147 plays an important role in
the modulation of cell phagocytosis. In previous study
[27], it was shown that the effective potency of
TMEM63A was the same to TMEM147. However, the
real functions of these two proteins or their collabor-
ation in the regulation of phagocytosis still needs further
research.
Nitric oxide (NO) has been implicated in host non-
specific defence against a variety of infections and play
roles in a number of parasitic infections such as malaria,
toxoplasmosis, leishmaniosis, trypanosomosis and schis-
tosomosis [38]. In this study, nitric oxide production in
147 siRNA/g group was significantly increased compared
to the 147 siRNA group and ns siRNA/g group (Fig. 6).
In the study of TMEM63A, the nitric oxide production
in the 63A siRNA/g group was significantly increased
compared to the ns siRNA/g group, while the produc-
tion in 63A siRNA/g group was still significantly lower
than that in the 63A siRNA group [27]. These findings
revealed that rHco-gal-m inhibited the nitric oxide pro-
duction by interactions with TMEM147 and TMEM63A.
However, TMEM147 might play a greater role than
TMEM63A in the rHco-gal-m-mediated regulation of
nitric oxide production on goat PBMC.
It was demonstrated that rHco-gal-m/f significantly de-
creased the ability of cell migration in goat PBMC [25].
This description was further supported by our data. How-
ever, the significant decrease induced by rHco-gal-m was
not changed by the TMEM147 siRNA-treatment (Fig. 7).
In the study of TMEM63A, the suppression of cell migra-
tion induced by rHco-gal-m in the ns siRNA/g group was
significantly changed by TMEM63A siRNA-treatment
[27]. These results indicated that it was TMEM63A, not
TMEM147, involved in the rHco-gal-m-mediated regula-
tion of cell migration on goat PBMC.
It was reported that many members of galectin family
were implicated in the regulation of cell apoptosis [39–41],
and rHco-gal-m could induce cell apoptosis in goat PBMC
[26, 28]. In this study, TMEM147 siRNA-treatment could
significantly decrease cell apoptosis induced by rHco-gal-m
(Fig. 8). Our data strongly suggest that TMEM147 was in-
volved in the regulation of PBMC apoptosis induced by
rHco-gal-m.
Cytokines play an important role in regulating devel-
opment, differentiation and expression of functional
effecters of the immune system, and the profile of im-
mune reactions depends on cytokine contents at the rec-
ognition of parasite [42–45]. Recent studies reported
that galectin-1 could affect the Th1/Th2 balance by me-
diating Th1 cell apoptosis and stimulating Th2 cytokine
secretion [46], and IL-10 played important roles in medi-
ating the immunosuppressive activities of galectin-1
[47]. Our previous studies demonstrated that rHco-gal-m
increased the mRNA transcript levels of IL-10 and TGF-β1,
whilst decreasing the transcription levels of IFN-γ [27, 29].
In this study, TMEM147 siRNA-treatment significantly
decreased the transcript levels of IFN-γ either in the
rHco-gal-m treated group or in the PBS control group
(Fig. 9). In the study of TMEM63A, TMEM63A siRNA-
treatment could significantly enhance the transcription of
IFN-γ in both rHco-gal-m treated and PBS control groups
[27]. It was suggested that the inhibition of IFN-γ tran-
scription induced by rHco-gal-m was mainly mediated by
TMEM63A. The results also showed that the enhance-
ment of IL-10 and TGF-β1 transcription induced by
rHco-gal-m in the ns siRNA groups were reversed by
TMEM147 siRNA-treatment (Fig. 9), while slightly de-
creased by TMEM63A siRNA-treatment [27]. These indi-
cated that the rHco-gal-m enhanced the transcription of
IL-10 and TGF-β1 mainly through the interaction with
TMEM147. The real regulation mechanisms of cytokines
requires further research.
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Conclusions
Our data strongly suggest that TMEM147 is a binding
partner or a membrane receptor for Hco-gal-m/f in goat
PBMC. The interaction of galectin with TMEM147 mainly
mediated cell proliferation, cell apoptosis, transcription of
IL-10 and TGF-β1 of goat PBMC. This membrane pro-
tein, together with TMEM63A, was also related to the
regulation of galectin on phagocytosis and nitric oxide
production of goat PBMC. It is worth noting that
TMEM63A might play a greater role than TMEM147 in
the regulation of galectin in the migration and IFN-γ tran-
scription of goat PBMC. These findings delivered new
clues to the elucidation of the mechanisms involved in im-
mune evasion by nematodes and in parasite-host interac-
tions. However, the detailed functions of TMEM147 and
TMEM63A in the regulation of galectin on the goat
PBMC are still needed for further research.
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